US FDA grants clearance for the use of Verdeca’s HB4 stress-tolerant soybeans in human food

8cbd8b5a-716e-45e1-8dc2-75e602e028c8articleimage.jpg

11 Aug 2017 --- Arcadia Biosciences Inc. and Bioceres S.A. have announced that the US Food and Drug Administration (FDA) has completed its full review of the safety evaluation for HB4 soybeans, produced by their joint venture, Verdeca. The FDA’s notice to Verdeca allows products derived from HB4 soybeans to be used commercially in human food and animal feed.

The US FDA uses its Biotechnology Notice process to review and assess safety data provided by companies developing new plant varieties using advanced breeding technologies. The data provided to the FDA is consistent with international regulatory requirements for genetically modified crops and will be used by Verdeca and its global partners for future regulatory submissions, the companies report.

Verdeca’s HB4 soybeans have undergone extensive testing, including multi-location field trials in Argentina and the US and multiple regulatory field trials. The results of these trials demonstrate that the HB4 trait can provide yield advantages under stress conditions – including drought and low-water conditions – found in several soybean production areas.

“The HB4 gene holds great promise for bringing better yield stability to agriculture in areas that experience chronic water stress problems,” says Raj Ketkar, President and CEO of Arcadia Biosciences. “Our combined efforts aim to create significant value for soybean growers by increasing the productivity and sustainability of this important protein crop in the face of global climate challenges.”

“The FDA is one of the most prestigious regulatory agencies in the world, and its opinions are of reference to regulators everywhere,” says Federico Trucco, CEO of Bioceres. “In a way, this FDA clearance testifies to the quality standards implemented in HB4 product development and safety evaluations. We hope this decision will help expedite international regulatory clearances for HB4 soybeans, and bring us closer to the much-anticipated launch of this unique technology.”

Completion of the FDA’s review is another key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The trait has already been approved in Argentina by the Ministry of Agriculture, Livestock and Fisheries.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Food for thought: Suppliers on the cognitive health ingredients market 

13 Jul 2018 --- Cognitive health has proven itself a growing category, with new products appealing to consumers from all walks of life, from more senior citizens seeking to prevent cognitive decline, to busy office workers looking to combat mental fatigue. NutritionInsight speaks to suppliers about their views on this growing category.

Nutrition & Health News

Study: Stop avoiding whole dairy products for heart health

12 Jul 2018 --- New research at The University of Texas could banish the feeling of guilt some consumers may have around consuming whole dairy products amid conflicting information about fats and heart health. The study, published in the American Journal of Clinical Nutrition, found no significant link between dairy fats and cause of death, or, more specifically, heart disease and stroke – two of the US’s biggest killers. In fact, certain types of dairy fat may help guard against having a severe stroke, the researchers reported.

Nutrition & Health News

Crystal structure reveals curcumin‘s potential to impair cancer

10 Jul 2018 --- Curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 (DYRK2) at the atomic level, leading to inhibition of DYRK2 that impairs cell proliferation and reduces cancer burden, a research team from University of California San Diego School of Medicine, Peking University and Zhejiang University have found. The research team found this previously unreported biochemical interaction through x-ray crystallography and kinase-inhibitor specificity profiling. However, before turning to curcumin or turmeric supplements, Sourav Banerjee, Ph.D., UC San Diego School of Medicine postdoctoral scholar, cautions that curcumin alone may not be the answer.

Business News

Plant-based strategy: Dean Foods increases investment in flaxseed dairy alternatives brand

04 Jul 2018 --- Dean Foods Company has increased its ownership percentage and taken a majority stake in Good Karma Foods, a US brand known for its flaxseed-based milk and yogurt alternatives. The investment points to Dean Foods' commitment to plant-based foods and beverages at a time when more and more consumers are looking to minimize their consumption of animal-derived products.

Nutrition & Health News

“Shockingly” salty salads on UK high street, lobby group calls for action

19 Jun 2018 --- A nationwide product survey by UK lobby group Action on Salt highlights the high salt and saturated fat levels of restaurant, retail and fast food salads. The group, based at the Wolfson Institute, Barts & The London, Queen Mary University of London, found that the salt content of salads bought from restaurants, sandwich/coffee shops and fast food outlets has increased by 13 percent since they were last surveyed in 2014 (from 1.65g to 1.86g per serving on average), flagging “a distinct lack of commitment” from the food industry to reduce salt, according to the group.

More Articles
URL : http://www.nutritioninsight.com:80/news/US-FDA-grants-clearance-for-the-use-of-Verdecas-HB4-stress-tolerant-soybeans-in-human-food.html